TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2695009

Group type: EXPERIMENTAL
Intervention: 1 week of immobilization
Number of subjects: 85

Group type: COMPARATOR
Intervention: 3 weeks of immobilization
Number of subjects: 85
Study: 331760

Group type: EXPERIMENTAL
Intervention: anti-influenza lactoglobulin
Number of subjects: 6361
Study: 31465720

Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Vitamin C (2 g)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 29424935

Group type: EXPERIMENTAL
Intervention: Extended hours haemodialysis (≥24 h/week)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard hours haemodialysis (target 12‐15 h)
Number of subjects: 200
Study: 27647820

Group type: EXPERIMENTAL
Intervention: Active cannabis brownie (6.9% THC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active smoked cannabis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral cannabis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhaled routes (smoked or vaporized)
Number of subjects: 0
Study: 26052057

Group type: EXPERIMENTAL
Intervention: Proximal femoral nailing
Number of subjects: 54

Group type: COMPARATOR
Intervention: Cemented hemiarthroplasty
Number of subjects: 54
Study: 24855129

Group type: EXPERIMENTAL
Intervention: Motivational interviewing training for clinicians
Number of subjects: 134

Group type: COMPARATOR
Intervention: IPS-only teams (control)
Number of subjects: 134
Study: 21830318

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pressure Trigger
Number of subjects: 18

Group type: COMPARATOR
Intervention: Flow Trigger
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 18
Study: 19641971

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 0
Study: 17803059

Group type: EXPERIMENTAL
Intervention: Vazkor 10 mg tablet (test preparation)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 10 mg tablet of the originator product (reference preparation)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both test and reference preparations
Number of subjects: 18
Study: 15217803

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (120 mg vitamin C, 30 mg vitamin E, 6 mg beta carotene, 100 microg selenium, and 20 mg zinc)
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 1162
Study: 11427639

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Vitamin C (250 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of vitamins E and C
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9723560

Group type: EXPERIMENTAL
Intervention: Allergic rhinitis with methacholine hyperresponsiveness
Number of subjects: 40

Group type: COMPARATOR
Intervention: Allergic rhinitis with normal methacholine responsiveness
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 7981777

Group type: EXPERIMENTAL
Intervention: GH 0.1 mg/kg/day (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 20
Study: 3057036

Group type: EXPERIMENTAL
Intervention: diltiazem (360 mg/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: nifedipine (120 mg/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: diltiazem and nifedipine
Number of subjects: 21
Study: 488802

Group type: EXPERIMENTAL
Intervention: Early ambulation within 24-72 hours
Number of subjects: 286

Group type: COMPARATOR
Intervention: Bed rest for the first seven days
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Early ambulation
Number of subjects: 286
Study: 30460734

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 25193946

Group type: EXPERIMENTAL
Intervention: Oxytocin (24 I.U.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23624215

Group type: EXPERIMENTAL
Intervention: Silymarin (420mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desferrioxamine (40mg/kg/day) + Silymarin (420mg daily)
Number of subjects: 30
Study: 21853784

Group type: EXPERIMENTAL
Intervention: Kapalabhati
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Breath awareness
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (nonyoga practitioners)
Number of subjects: 30
Study: 19623172

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA) withdrawal
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Aminosalicylates
Number of subjects: 127
Study: 17371601

Group type: EXPERIMENTAL
Intervention: Goal Directed Therapy (GDT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study: 15550792

Group type: EXPERIMENTAL
Intervention: ANP-treated group (n = 13, 0.05 microg/kg/min of synthetic human alpha-ANP administered postoperatively)
Number of subjects: 26
Study: 11075311

Group type: EXPERIMENTAL
Intervention: Piroxicam-beta-cyclodextrin (PBCD) 20 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Piroxicam (Feldene) 20 mg
Number of subjects: 48
Study: 9108811

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fluvoxamine
Number of subjects: 64
Study: 8211041

Group type: EXPERIMENTAL
Intervention: Sustained-release bezafibrate 400 mg per day for 56 days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo for 56 days
Number of subjects: 31
Study: 3518049

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cefotetan
Number of subjects: 14
Study: 30466131

Group type: EXPERIMENTAL
Intervention: Alginate therapy (up to 4 times daily for 14 days)
Number of subjects: 155
Study: 29345158

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: LC‐PUFA
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Probiotics and LC‐PUFA
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 26945497

Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy with Dermatophagoides pteronyssinus after 2 months of placebo in polysensitized patients.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy with Dermatophagoides pteronyssinus after 2 months of placebo in monosensitized patients.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy with Dermatophagoides pteronyssinus in both groups.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy with Dermatophagoides pteronyssinus in polysensitized patients.
Number of subjects: 43
Study: 25927907

Group type: EXPERIMENTAL
Intervention: Early palliative care consultation added to standard care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 90
Study: 23151221

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation (single RDA of vitamins B1, B2, B6, B12, niacin, C, E, and folic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 0
Study: 20303236

Group type: EXPERIMENTAL
Intervention: Fat-free milk (400 mL daily for mild, 600 mL for moderate, 800 mL for severe constipation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Whole milk (400 mL for 3 days)
Number of subjects: 30
Study: 17953047

Group type: EXPERIMENTAL
Intervention: Paradigm Real-Time System
Number of subjects: 0
Study: 16301159

Group type: EXPERIMENTAL
Intervention: Aqueous Ca(OH)2 slurry mixed with 2% chlorhexidine (CHX)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aqueous Ca(OH)2 slurry alone
Number of subjects: 40
Study: 12085028

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment (injection of epinephrine, mechanical removal of clot, coagulation)
Number of subjects: 56
Study: 9527083

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 17)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 36
Study: 8591078

Group type: EXPERIMENTAL
Intervention: FAM chemotherapy (5-FU, doxorubicin, mitomycin C) for 1 year (6 cycles)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Surgery alone (observation only)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: FAM chemotherapy
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Curative surgical resection
Number of subjects: 193
Study: 1977760

Group type: EXPERIMENTAL
Intervention: 10 micrograms CV (iv)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 5 micrograms CV (iv)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2.5 micrograms CV (iv)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 1 microgram CV (iv)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 100 micrograms CV (orally)
Number of subjects: 27
Study: 103722

Group type: EXPERIMENTAL
Intervention: Atropine (0.5 mg i.v. and 0.5 mg s.c.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium infusion (0.3 mmol/kg.105 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (0.12 mmol/kg.45 min)
Number of subjects: 0
Study: 30551730

Group type: EXPERIMENTAL
Intervention: Whole Body Cryotherapy (WBC) - 3‐min at ‐40°C, wind speed of 2.3 m s‐1
Number of subjects: 22

Group type: COMPARATOR
Intervention: Passive Recovery (Control)
Number of subjects: 22
Study: 28129548

Group type: EXPERIMENTAL
Intervention: Dru yoga intervention (n=16): one-hour session each week for 4 weeks and a 20-minute DVD for home practice.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (n=16): no intervention.
Number of subjects: 32
Study: 25841214

Group type: EXPERIMENTAL
Intervention: Low-cost improved cooking stoves
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (traditional cooking methods)
Number of subjects: 0
Study: 23434613

Group type: EXPERIMENTAL
Intervention: Self-management intervention using motivational interviewing strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-management intervention
Number of subjects: 0
Study: 21385361

Group type: EXPERIMENTAL
Intervention: Pedalling daily for up to ten minutes, for up to ten working days (experimental group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Routine rehabilitation (all participants)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pedalling (experimental group)
Number of subjects: 24
Study: 20032909

Group type: EXPERIMENTAL
Intervention: Patient-Specific Index for physiotherapy (PSI-PD)
Number of subjects: 81
Study: 17341317

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol 5 mg after formoterol treatment
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 mug after formoterol treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nebulised salbutamol 5 mg after placebo treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ipratropium bromide 40 mug after placebo treatment
Number of subjects: 22
Study: 14987299

Group type: EXPERIMENTAL
Intervention: Heat-inactivated BCG (0.1 mL injection once a week for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 31
Study: 11251566

Group type: EXPERIMENTAL
Intervention: 4 weeks of terbinafine (62.5 mg daily for <20 kg, 125 mg daily for 20-40 kg, 250 mg daily for >40 kg)
Number of subjects: 210

Group type: COMPARATOR
Intervention: 8 weeks of griseofulvin (10 mg/kg daily)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 4 weeks of terbinafine in patients with Trichophyton infections weighing >20 kg
Number of subjects: 210
Study: 9256560

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance ratings by clients or therapists in outpatient sample
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapists ratings of the alliance in the aftercare sample
Number of subjects: 0

Group type: COMPARATOR
Intervention: Therapeutic alliance ratings by aftercare clients
Number of subjects: 0
Study: 8297488

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (DuoDERM CGF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Moist gauze dressings
Number of subjects: 70
Study: 3440634

Group type: EXPERIMENTAL
Intervention: Piretanide (3 to 12 mg daily for 12 weeks)
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Triamterene (with and without piretanide) and amiloride in combination with hydrochlorothiazide
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Piretanide
Number of subjects: 188
Study: 29168570

Group type: EXPERIMENTAL
Intervention: Phleum pratense subcutaneous immunotherapy (Phl‐SCIT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 28654972

Group type: EXPERIMENTAL
Intervention: Electronic pill bottles combined with lottery incentives and social support for medication adherence (1003 patients)
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Usual care (506 patients)
Number of subjects: 1509
Study: 25893563

Group type: EXPERIMENTAL
Intervention: Dehydration (DH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Euhydration (EH)
Number of subjects: 10
Study: 23061492

Group type: EXPERIMENTAL
Intervention: Usual care plus telephone support (UC+I)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 405
Study: 21621993

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 40% of maximal inspiratory pressure (MIP) for 6 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham therapy (15% of MIP) for 6 weeks
Number of subjects: 30
Study: 18959604

Group type: EXPERIMENTAL
Intervention: Insulin detemir (n = 125)
Number of subjects: 271

Group type: COMPARATOR
Intervention: NPH insulin (n = 146)
Number of subjects: 271
Study: 16822113

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Exposure plus applied relaxation (EXP = AR)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Wait-list (WAIT)
Number of subjects: 62
Study: 12659241

Group type: EXPERIMENTAL
Intervention: Ejaculation followed by 7 days of abstinence
Number of subjects: 28

Group type: COMPARATOR
Intervention: Continuous abstinence after ejaculation
Number of subjects: 28
Study: 10194085

Group type: EXPERIMENTAL
Intervention: Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis (DTaP) vaccine
Number of subjects: 2187

Group type: EXPERIMENTAL
Intervention: Lederle whole‐cell component diphtheria and tetanus toxoids and pertussis (DTP) vaccine
Number of subjects: 2187

Group type: COMPARATOR
Intervention: Diphtheria and tetanus toxoids (DT) vaccine
Number of subjects: 2187
Study: 8546476

Group type: EXPERIMENTAL
Intervention: Granisetron hydrochloride 3 mg/body administered by intravenous drip before chemotherapy (group A)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Granisetron hydrochloride 3 mg/body administered by intravenous drip before chemotherapy (group B)
Number of subjects: 22
Study: 1858704

Group type: EXPERIMENTAL
Intervention: L-amino acid diets providing 40 mg leucine.kg-1.d-1
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: L-amino acid diets providing 15 mg leucine.kg-1.d-1
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Variable amounts of valine and isoleucine
Number of subjects: 11
Study: 6137857

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Zopiclone 10 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Zopiclone 5 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30586223

Group type: EXPERIMENTAL
Intervention: Training materials including expert eye gaze
Number of subjects: 21

Group type: COMPARATOR
Intervention: Training materials without expert eye gaze
Number of subjects: 21
Study: 26261865

Group type: EXPERIMENTAL
Intervention: Long-term combination programme (CP) comprising short-term day-hospital treatment followed by outpatient combined group and individual psychotherapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Outpatient individual psychotherapy (OIP)
Number of subjects: 52
Study: 26030319

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison group (job club approach with peer support)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: IPS
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 85
Study: 22865153

Group type: EXPERIMENTAL
Intervention: Bright white light (BWL, n = 23)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Dim red light (DRL, n = 16)
Number of subjects: 39
Study: 20499131

Group type: EXPERIMENTAL
Intervention: 2ME2 NanoCrystal® dispersion (NCD) at 1,500 mg orally four times daily, repeated in 28 day cycles
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 2ME2 NanoCrystal® dispersion (NCD)
Number of subjects: 21
Study: 20137600

Group type: EXPERIMENTAL
Intervention: Unicompartmental knee arthroplasty (UKA)
Number of subjects: 415

Group type: COMPARATOR
Intervention: High tibial osteotomy (HTO)
Number of subjects: 415
Study: 16670385

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Number of subjects: 1031
Study: 15277317

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg/d for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 30
Study: 11896110

Group type: COMPARATOR
Intervention: CT (cisplatin and dacarbazine every 21 days)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: bioCT (CT regimen followed by low-dose subcutaneous IL-2 for 8 days and IFN alpha-2b three times a week for six cycles)
Number of subjects: 176
Study: 9869892

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azathioprine treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 8560289

Group type: EXPERIMENTAL
Intervention: Periconceptional folic acid supplementation
Number of subjects: 0
Study: 2283644

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg once daily
Number of subjects: 173

Group type: COMPARATOR
Intervention: Atenolol 50 mg once daily
Number of subjects: 173
Study: 378017

Group type: EXPERIMENTAL
Intervention: Atropine (0.01 mg/kg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Glycopyrrolate (0.004 mg/kg)
Number of subjects: 2
Study: 6342838

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 1884

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1884
Study: 30945664

Group type: EXPERIMENTAL
Intervention: MdHOXs under cold treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: MdHOXs under osmotic treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: MdHOXs under high salinity treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: MdHOXs under exogenous ABA treatment
Number of subjects: 207
Study: 29676530

Group type: EXPERIMENTAL
Intervention: lorcaserin
Number of subjects: 137

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 137
Study: 27349906

Group type: EXPERIMENTAL
Intervention: Intervention group (self-management program)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Control group (attention control program)
Number of subjects: 174
Study: 25424121

Group type: EXPERIMENTAL
Intervention: L-carnitine (4 g/day intravenous)
Number of subjects: 30
Study: 22876543

Group type: COMPARATOR
Intervention: Pamidronate (PAM), 1 mg/kg/day over 2 days
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL), 0.025-0.05 mg/kg/day over 2 days every 3-4 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Pamidronate (PAM)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL)
Number of subjects: 23
Study: 20460412

Group type: EXPERIMENTAL
Intervention: Gain-framed health or appearance messages for individuals high in body consciousness
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Gain-framed health or appearance messages for individuals low in body consciousness
Number of subjects: 390

Group type: COMPARATOR
Intervention: Loss-framed messages
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (no specific message framing)
Number of subjects: 390
Study: 18820247

Group type: EXPERIMENTAL
Intervention: Pre-magnesium (bolus of magnesium 50 mg epidurally before induction, followed by infusion of 10 mg h(‐1) until end of surgery)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Post-magnesium (epidural saline during the same time periods plus bolus epidural magnesium 50 mg at the end of surgery)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (epidural saline during all three periods)
Number of subjects: 90
Study: 15661415

Group type: EXPERIMENTAL
Intervention: Pfannenstiel laparotomy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Vertical laparotomy
Number of subjects: 69
Study: 12423847

Group type: EXPERIMENTAL
Intervention: Water soluble lubricant
Number of subjects: 182

Group type: COMPARATOR
Intervention: Warm water
Number of subjects: 182
Study: 10514160

Group type: EXPERIMENTAL
Intervention: Local injection of 20 mg methylprednisolone plus lignocaine
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice daily for two weeks
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 164
Study: 7671364

Group type: EXPERIMENTAL
Intervention: Higher dose of digoxin (0.39 +/- 0.11 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 1866609

Group type: EXPERIMENTAL
Intervention: Monofunctional dentin adhesive without linings
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bifunctional dentin adhesive without linings
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Monofunctional dentin adhesive with linings
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bifunctional dentin adhesive with linings
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bifunctional dentin adhesive 'Prisma Universal Bond 2'
Number of subjects: 77

Group type: COMPARATOR
Intervention: In-vitro specimens (control group)
Number of subjects: 77
Study: 7009103

Group type: EXPERIMENTAL
Intervention: Groundnut oil or safflower oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PUFA rich oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 0
Study: 31393600

Group type: EXPERIMENTAL
Intervention: Chairside bacterial test (CST)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Quantitative polymerase chain reaction (qPCR)
Number of subjects: 125